155 related articles for article (PubMed ID: 27655710)
1. TERT rs2853676 polymorphisms correlate with glioma prognosis in Chinese population.
He X; Wei Y; Chen Z; Zhu X; Ma L; Zhang N; Zhang Y; Kang L; Yuan D; Zhang Z; Jin T
Oncotarget; 2016 Nov; 7(45):73781-73791. PubMed ID: 27655710
[TBL] [Abstract][Full Text] [Related]
2. The effects of gene polymorphisms on glioma prognosis.
Cui Y; Li G; Yan M; Li J; Jin T; Li S; Mu S
J Gene Med; 2017 Nov; 19(11):345-352. PubMed ID: 28985021
[TBL] [Abstract][Full Text] [Related]
3. RTEL1 and TERT polymorphisms are associated with astrocytoma risk in the Chinese Han population.
Jin TB; Zhang JY; Li G; Du SL; Geng TT; Gao J; Liu QP; Gao GD; Kang LL; Chen C; Li SQ
Tumour Biol; 2013 Dec; 34(6):3659-66. PubMed ID: 23812731
[TBL] [Abstract][Full Text] [Related]
4. The polymorphisms (rs3213801 and rs5744533) of DNA polymerase kappa gene are not related with glioma risk and prognosis: A case-control study.
Wu Y; Zhou L; Deng Y; Li N; Yang P; Dong S; Yang S; Zheng Y; Yao L; Zhang M; Zhai Z; Dai Z; Wu Y
Cancer Med; 2019 Dec; 8(17):7446-7453. PubMed ID: 31595696
[TBL] [Abstract][Full Text] [Related]
5. TERT gene polymorphisms are associated with chronic obstructive pulmonary disease risk in the Chinese Li population.
Ding Y; Li Q; Wu C; Wang W; Zhao J; Feng Q; Zhou X; Xie Y; Lin M; He P; Xie P
Mol Genet Genomic Med; 2019 Aug; 7(8):e773. PubMed ID: 31270965
[TBL] [Abstract][Full Text] [Related]
6. Selected polymorphisms of GSTP1 and TERT were associated with glioma risk in Han Chinese.
Li G; Jin TB; Wei XB; He SM; Liang HJ; Yang HX; Cui Y; Chen C; Cai LB; Gao GD
Cancer Epidemiol; 2012 Dec; 36(6):525-7. PubMed ID: 22795327
[TBL] [Abstract][Full Text] [Related]
7. Polymorphism in the IL4R gene and clinical features are associated with glioma prognosis: Analyses of case-cohort studies.
Jin TB; Du S; Zhu XK; Li G; Ouyang Y; He N; Zhang Z; Zhang Y; Kang L; Yuan D
Medicine (Baltimore); 2016 Aug; 95(31):e4231. PubMed ID: 27495027
[TBL] [Abstract][Full Text] [Related]
8. Impact of four lncRNA polymorphisms (rs2151280, rs7763881, rs1136410, and rs3787016) on glioma risk and prognosis: A case-control study.
Deng Y; Zhou L; Li N; Wang M; Yao L; Dong S; Zhang M; Yang P; Hao Q; Wu Y; Lyu L; Jin T; Dai Z; Kang H
Mol Carcinog; 2019 Dec; 58(12):2218-2229. PubMed ID: 31489712
[TBL] [Abstract][Full Text] [Related]
9. TERT promoter mutations in gliomas, genetic associations and clinico-pathological correlations.
Labussière M; Di Stefano AL; Gleize V; Boisselier B; Giry M; Mangesius S; Bruno A; Paterra R; Marie Y; Rahimian A; Finocchiaro G; Houlston RS; Hoang-Xuan K; Idbaih A; Delattre JY; Mokhtari K; Sanson M
Br J Cancer; 2014 Nov; 111(10):2024-32. PubMed ID: 25314060
[TBL] [Abstract][Full Text] [Related]
10. Impact of AKAP6 polymorphisms on Glioma susceptibility and prognosis.
Zhang M; Zhao Y; Zhao J; Huang T; Wu Y
BMC Neurol; 2019 Nov; 19(1):296. PubMed ID: 31759389
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of Genetic Variants in MIR3142HG in Susceptibility to and Prognosis of Glioma.
Guo X; Zhang M; Li Q; Zhao J; Wang B; Wang J; Mao P; Song J
Am J Clin Oncol; 2020 Jan; 43(1):1-8. PubMed ID: 31513017
[TBL] [Abstract][Full Text] [Related]
12. Genetic variants in telomerase-related genes are associated with an older age at diagnosis in glioma patients: evidence for distinct pathways of gliomagenesis.
Walsh KM; Rice T; Decker PA; Kosel ML; Kollmeyer T; Hansen HM; Zheng S; McCoy LS; Bracci PM; Anderson E; Hsuang G; Wiemels JL; Pico AR; Smirnov I; Molinaro AM; Tihan T; Berger MS; Chang SM; Prados MD; Lachance DH; Sicotte H; Eckel-Passow JE; Wiencke JK; Jenkins RB; Wrensch MR
Neuro Oncol; 2013 Aug; 15(8):1041-7. PubMed ID: 23733245
[TBL] [Abstract][Full Text] [Related]
13. TERT promoter mutation confers favorable prognosis regardless of 1p/19q status in adult diffuse gliomas with IDH1/2 mutations.
Arita H; Matsushita Y; Machida R; Yamasaki K; Hata N; Ohno M; Yamaguchi S; Sasayama T; Tanaka S; Higuchi F; Iuchi T; Saito K; Kanamori M; Matsuda KI; Miyake Y; Tamura K; Tamai S; Nakamura T; Uda T; Okita Y; Fukai J; Sakamoto D; Hattori Y; Pareira ES; Hatae R; Ishi Y; Miyakita Y; Tanaka K; Takayanagi S; Otani R; Sakaida T; Kobayashi K; Saito R; Kurozumi K; Shofuda T; Nonaka M; Suzuki H; Shibuya M; Komori T; Sasaki H; Mizoguchi M; Kishima H; Nakada M; Sonoda Y; Tominaga T; Nagane M; Nishikawa R; Kanemura Y; Kuchiba A; Narita Y; Ichimura K
Acta Neuropathol Commun; 2020 Nov; 8(1):201. PubMed ID: 33228806
[TBL] [Abstract][Full Text] [Related]
14. The prognostic impact of TERT promoter mutations in glioblastomas is modified by the rs2853669 single nucleotide polymorphism.
Batista R; Cruvinel-Carloni A; Vinagre J; Peixoto J; Catarino TA; Campanella NC; Menezes W; Becker AP; de Almeida GC; Matsushita MM; Clara C; Neder L; Viana-Pereira M; Honavar M; Castro L; Lopes JM; Carvalho B; Vaz RM; Máximo V; Soares P; Sobrinho-Simões M; Reis RM; Lima J
Int J Cancer; 2016 Jul; 139(2):414-23. PubMed ID: 26914704
[TBL] [Abstract][Full Text] [Related]
15. Fine-mapping of a region of chromosome 5p15.33 (TERT-CLPTM1L) suggests a novel locus in TERT and a CLPTM1L haplotype are associated with glioma susceptibility in a Chinese population.
Zhao Y; Chen G; Zhao Y; Song X; Chen H; Mao Y; Lu D
Int J Cancer; 2012 Oct; 131(7):1569-76. PubMed ID: 22213090
[TBL] [Abstract][Full Text] [Related]
16. IL-10 and PRKDC polymorphisms are associated with glioma patient survival.
Hu M; Du J; Cui L; Huang T; Guo X; Zhao Y; Ma X; Jin T; Li G; Song J
Oncotarget; 2016 Dec; 7(49):80680-80687. PubMed ID: 27811370
[TBL] [Abstract][Full Text] [Related]
17. Association of TERT-CLPTM1L and 8q24 Common Genetic Variants with Gallbladder Cancer Susceptibility and Prognosis in North Indian Population.
Yadav S; Chandra A; Kumar A; Mittal B
Biochem Genet; 2018 Aug; 56(4):267-282. PubMed ID: 29450669
[TBL] [Abstract][Full Text] [Related]
18. TERT promoter mutations contribute to subset prognostication of lower-grade gliomas.
Chan AK; Yao Y; Zhang Z; Chung NY; Liu JS; Li KK; Shi Z; Chan DT; Poon WS; Zhou L; Ng HK
Mod Pathol; 2015 Feb; 28(2):177-86. PubMed ID: 25081751
[TBL] [Abstract][Full Text] [Related]
19. TERT promoter mutations contribute to IDH mutations in predicting differential responses to adjuvant therapies in WHO grade II and III diffuse gliomas.
Zhang ZY; Chan AK; Ding XJ; Qin ZY; Hong CS; Chen LC; Zhang X; Zhao FP; Wang Y; Wang Y; Zhou LF; Zhuang Z; Ng HK; Yan H; Yao Y; Mao Y
Oncotarget; 2015 Sep; 6(28):24871-83. PubMed ID: 26314843
[TBL] [Abstract][Full Text] [Related]
20. Effects of the MAML2 genetic variants in glioma susceptibility and prognosis.
Zhang M; Zhao Y; Zhao J; Huang T; Guo X; Ma X; Wu Y
Biosci Rep; 2019 Oct; 39(10):. PubMed ID: 31652449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
